Spotlight on International Quality: COVID-19 and Its Impact on Quality Improvement in Cancer Care

Author:

Blayney Douglas W.1,Bariani Giovanni2,Das Devika3,Dawood Shaheenah4ORCID,Gnant Michael5,De Guzman Roselle6ORCID,Martin S. Eric7,O'Mahony Deirdre8,Roach Alex9,Ruff Paul10,Sampaio Carlos11ORCID,Sanchez Jose Angel12,Vanderpuye Verna13ORCID,Kamal Arif14ORCID,Hendricks Carolyn15

Affiliation:

1. Stanford Cancer Institute, Stanford University, Stanford, CA

2. Hospital Sirio Libanes, São Paulo, Brazil

3. Hematology Oncology at The Kirklin Clinic of University of Alabama, Birmingham, AL

4. Mediclinic City Hospital Dubai, Dubai, United Arab Emirates

5. Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

6. Manila Central University-FDTMF Hospital, Caloocan, Philippines

7. Medical Oncology Hematology Consultants, Wilmington, DE

8. Bon Secours Cork Cancer Centre, Cork, Ireland

9. Teladoc Health, Washington, DC

10. University of the Witwatersrand, Johannesburg, South Africa

11. Clinica AMO Salvador, Brazil

12. Hospital Escuela, University of Honduras, Tegucigalpa, Honduras

13. National Center for Radiotherapy Oncology and Nuclear Medicine, Accra, Ghana

14. Duke University School of Medicine, Durham, NC

15. Maryland Oncology Hematology, Bethesda, MD

Abstract

This report from ASCO's International Quality Steering Group summarizes early learnings on how the COVID-19 pandemic and its stresses have disproportionately affected cancer care delivery and its delivery systems across the world. This article shares perspectives from eight different countries, including Austria, Brazil, Ghana, Honduras, Ireland, the Philippines, South Africa, and the United Arab Emirates, which provide insight to their unique issues, challenges, and barriers to quality improvement in cancer care during the pandemic. These perspectives shed light on some key recommendations applicable on a global scale and focus on access to care, importance of expanding and developing new treatments for both COVID-19 and cancer, access to telemedicine, collecting and using COVID-19 and cancer registry data, establishing measures and guidelines to further enhance quality of care, and expanding communication among governments, health care systems, and health care providers. The impact of the COVID-19 pandemic on cancer care and quality improvement has been and will continue to be felt across the globe, but this report aims to share these experiences and learnings and to assist ASCO's international members and our global fight against the pandemic and cancer.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3